Chemaxon newsroom

News

01 03 2022
< 1 minute

ISO certifications

ISO certifications

03 02 2022
< 1 minute

ChemAxon now uses Okta, the world’s #1 identity platform. Update your profile now.

What does this change mean? An even more secure platform and smooth account handling for all...

03 01 2022
< 1 minute

ChemAxon’s response to CVE-2021-44228 (“Log4Shell”) together with CVE-2021-45046

Updated 3 January, 2022 We are continuing to remediate the Log4j Java library remote code execution...

03 09 2021
3 minutes

ChemAxon update - changes to Java, .NET and OLE support

In the upcoming LTS (long term support) release, we are streamlining ChemAxon’s support of Java and...

03 09 2021
3 minutes

Pushing the limit of logP prediction accuracy: ChemAxon’s results for the SAMPL 6 blind challenge

SAMPL (Statistical Assessment of the Modeling of Proteins and Ligands) challenges are designed to...

03 09 2021
5 minutes

Challenges in Searching Ultra-large Chemical Libraries (APAC)

As all good Trekkies know – “space [is] the final frontier” – and it keeps throwing out challenges,...

03 09 2021
2 minutes

ChemAxon Provides Direct Link from MarvinSketch to Google Scholar and Google Patents

The new Google search button in MarvinSketch immediately sends the drawn structure as a query to...

03 09 2021
< 1 minute

Marvin Licensing Update

As you probably know, we have begun rolling out updates on Marvin licenses earlier this year. We...

03 09 2021
< 1 minute

Prediction driven design of hERG liability free compounds

Optimizing pharmacokinetics and toxicity attributes are profound objectives across all drug...

03 09 2021
5 minutes

Challenges in Searching Ultra-large Chemical Libraries

As all good Trekkies know – “space [is] the final frontier” – and it keeps throwing out challenges,...

03 09 2021
< 1 minute

a-tune Label.Printer now updated to print ChemAxon chemical structures

a-tune Label.Printer is an independent product that allows the printing of labels from any device...

03 09 2021
< 1 minute

COVID-19 Information

ChemAxon supports COVID-19 research efforts with free licenses available on certain products. These...